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Purpose: The ketogenic diet has been found to be safe and eﬀective in the treatment of drug resistant epilepsy in
childhood. The age range of children undergoing this treatment has steadily been going down. There is strong
evidence that it is a safe alternative in infants with drug resistant seizures. The American Academy of Pediatrics
strongly supports continuing a breast milk diet until infants are at least six months of age. The purpose of this
study is to evaluate the safety and eﬃcacy of the ketogenic diet in infants while maintaining a breast milk diet.
Method: This is a cohort study of 9 infants between the ages of 1 and 13 months with drug resistant epilepsy
treated with the ketogenic diet while maintained on breast milk. The data from the ﬁrst two patients was
gathered retrospectively while the other seven were studied prospectively.
Results: We show that all nine infants achieved and maintained ketosis eﬀectively. While one infant had no
change in seizure frequency, three were seizure free at the ﬁrst follow-up visit and four had a burden of seizure
reduction greater than 50%. The diet was overall well tolerated, although one child required a hospital stay for
dehydration and metabolic acidosis.
Conclusion: The ketogenic diet can be safely and eﬀectively initiated in infants while continuing human breast
milk feedings.

1. Introduction
Neonatal epilepsy remains a signiﬁcant problem. Several large
prospective studies have shown that up to 38% of infants with epilepsy
were classiﬁed as drug resistant epilepsies [1]. Furthermore, the outcome for these infants remains rather poor, with 17% dying and 49%
having an abnormal exam at the time of discharge [2]. Until recently
there were no guidelines for the treatment of seizures in the newborn.
The mainstay of treatment remains phenobarbital, with benzodiazepines generally used as second line [3]. In 2015 the International
League Against Epilepsy published its recommendations for the management of infantile seizures [4]. In this publication the ketogenic diet
was reported as possibly eﬀective in the treatment of generalized seizures and as the treatment of choice for epilepsy in infants with glucose
transporter deﬁciency type 1 syndrome and pyruvate dehydrogenase
deﬁciency.
The ketogenic diet has been found to be both safe and eﬀective in
infants and children. Various retrospective studies have shown that
most children tolerate the diet over prolonged periods of time [5,6].

Side eﬀects are typically manageable but may include gastrointestinal
disruptions, hypertriglyceridemia and nephrolithiasis. Several groups
have published data showing that the ketogenic diet is an eﬀective
treatment for epileptic spasms [7,8]. One of the barriers that may inﬂuence the choice of the ketogenic diet as a treatment for infants with
epilepsy is the desire for mothers to breastfeed. In 2012, the American
Academy of Pediatrics reaﬃrmed its recommendation of exclusively
breastfeeding infants for six months and asserted that breastfeeding
should be considered a public health issue [9]. This prompted our group
to design a protocol for initiating the ketogenic diet in breastfed infants.
We present the clinical follow-up of nine infants who were successfully
started on the ketogenic diet while maintaining human milk feedings.
2. Material and methods
This is a study of infants who received ketogenic diet therapy in the
Comprehensive Epilepsy Center at Children’s Mercy Hospital between
May 2005 and January 2016. The patients reported in this study were
part of a larger cohort of patients on the ketogenic diet followed at our
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Nine infants with drug resistant seizures were included in this study
(Table 1). The seizure etiologies were hypoxic ischemic encephalopathy
(1 patient), glucose transporter deﬁciency type 1 [1], epileptic spasms
[3], KCNQ2 epileptic encephalopathy [1], CDKL5 epileptic encephalopathy [1], Aicardi syndrome [1] and an infant with a generalized epileptic encephalopathy of unknown etiology. The average age at seizure
onset was 3 month old with a range of 1–7 months of age. The average
age at the time the diet was started was 6.7 months old with a range of
1 to 13 months of age. The infants had failed one to three antiepileptic
drugs at the time of onset of the diet. Antiepileptic medications used
included topiramate (6 patients), levetiracetam [5], clobazam [4],
clonazepam [3], vigabatrin [2], zonisamide [2], clorazepate [1],
ethosuximide [1], felbamate [1], lacosamide [1] and phenobarbital [1].
All of the patients were on a breast milk diet at the time of ketogenic
diet initiation; one remained on a breast milk diet for six months, ﬁve
for three months, and three for one month. All patients continued to be
followed in clinic every three months for as long as they were on the
ketogenic diet.
All of the patients achieved ketosis by the time of discharge (as
assessed
by
urine
ketones > 80 mg/dl
and
serum
betahydroxybutyrate > 1000μmole/L) and were still in ketosis at the time
of the ﬁrst follow-up visit (Fig. 1). While on the diet and still on breast
milk the infants gained an average of 9+/-19 points in weight percentiles (range -23 to +41, Table 1, all results are given as the average
value +/- the standard deviation). We collected lipid proﬁles for all
infants while on the diet. The average change in cholesterol was
+8.9+/-33.8 mg/dl (Table 1) and the average change in triglycerides
-18.6+/−113 mg/dl. However, not all infants had a repeat lipid proﬁle
at the time that breast milk was discontinued. In such cases we used
next available lipid proﬁle. We did not have enough data to ascertain
the statistical signiﬁcance of these changes. Serum glucose while on the
diet was on average 73+/−10 mg/dl (range: 60–99 mg/dl). Serum
bicarbonate was on average 21+/−4.3 mmol/L (range: 14–31 mmol/
L).
Four infants were seizure free and on no antiepileptic medications at
the time of breastmilk discontinuation. The parents of all but one infant
reported an improvement in perceived quality of life. While the infants
were maintained on breast milk the diet was generally well tolerated
with the exception of one infant who developed gastrointestinal side
eﬀects resulting in a brief hospitalization for dehydration and metabolic
acidosis.

Age at seizure onset
(months)

3. Results

Patient

Table 1
Clinical outcomes. QOL: Quality Of Life (parental perception of reported improvement in QOL), AED: Anti-Epileptic Drug, * all patients continued the ketogenic diet for at least three months after discontinuation of
breastmilk (see Fig. 1), **Required hospitalization for dehydration. ***Expressed as the change in mg/dl between ketogenic diet initiation and last visit while still on breast milk (NA: data not collected at diet initiation
for two patients whose ketogenic diet was initiated emergently in the NICU).

institution. We included all of the infants who were continued on
breastmilk at the time of diet initiation. The data from the ﬁrst two
patients was gathered retrospectively while the other seven were studied prospectively. The ketogenic diet was initiated per standard protocol (Charlie Foundation) during an inpatient admission. Patients were
all orally fed and began the diet at a 3:1 ratio. Mothers expressed breast
milk, which was subsequently mixed with ketogenic formula Ketocal
4:1(Nutricia North America) in eight of the nine patients, in patient 7 a
soy-based ketogenic formula had to be used (Ross Carbohydrate Free ®)
due to a milk protein allergy. Depending on the prescribed ketogenic
ratio (typically 3:1 to 4:1), the formula contained approximately 5–10%
calories from breastmilk, with more breastmilk in the 3:1 ratio and less
breastmilk in the 4:1 ratio. The Dietary Reference Intakes (DRI) for
protein for each subject was met for age and gender [10]. Seizure reduction (as reported by the parents in a seizure diary) and quality of life
(as reported by parents in the form of a yes/no question to improved
alertness, interactions, performance in school) were collected by means
of self-report during scheduled clinic visits. Serum beta-hydroxybutyrate levels and standard labs were collected at baseline, at 1
month follow up and every 3 months thereafter. This study was approved by the local IRB.
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Fig. 1. Serum betahydroxybutyrate levels after initiation of the ketogenic diet. The arrows indicate the end of the breast milk diet. X-axis: Treatment length in
months, Y-axis: Beta-hydroxybutyrate serum levels in μmol/L. Note that the one-month labs were not available for patients 1 and 3.

4. Discussion
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In this study we report nine breastfed infants with drug resistant
epilepsy treated successfully with the ketogenic diet. At the time of diet
initiation they were 1 to 13 months of age (average 6.7 months). All
nine infants were able to continue on a diet of breast milk for at least 1
month. The reasons for discontinuing breastmilk included a combination of factors, including reaching 6 months of age (AAP recommended
minimum length of time on breastmilk), loss of supply or decreased
interest in expressing breastmilk (see supplemental Table 1 for details).
All of the infants achieved ketosis prior to discharge (as measured by
urine ketones and serum beta-hydroxybutyrate levels) and maintained
ketosis (as measured by serum beta-hydroxybutyrate levels) at subsequent visits. No signiﬁcant side eﬀects were reported. Four of the
infants were seizure free and three had a greater than 50% seizure reduction. None of the infants had signiﬁcant side eﬀects from the
treatment. This is the largest reported cohort of breastfed infants
treated with the ketogenic diet. Two groups previously reported
[11,12] respectively ﬁve and four infants treated with the ketogenic
diet while on breast milk. The infants in both studies were slightly older
on average than our patients. Both groups showed a signiﬁcant decrease
in seizure burden. In the present study we expand on this experience.
We present a larger group of infants, all with treatment refractory
epilepsies. We show that in this group of infants the diet was eﬀectively
initiated while maintaining a breast milk diet. The results of the laboratory and biometric data support the eﬀectiveness and the safety of
the diet.
Drug resistant epilepsy in infants remains a signiﬁcant problem [2].
The use of the ketogenic diet in infants has been shown to be safe and
eﬀective and the International League Against Epilepsy now recognizes
it as a treatment option for these infants [4]. Given the American
Academy of Pediatrics’ strong endorsement of breast-feeding infants
and given the increased use of the ketogenic diet to treat drug resistant
epilepsy in infants, ﬁnding a solution that allows for maintenance of a
diet of breast milk while on the ketogenic diet is of importance. The
present report adds evidence supporting the safe and eﬀective use of the
ketogenic diet in breastfed infants with drug resistant epilepsy.

Appendix A. Supplementary data
Supplementary material related to this article can be found, in the
online version, at doi:https://doi.org/10.1016/j.seizure.2019.03.017.
References
[1] Eltze CM, Chong WK, Cox T, Whitney A, Cortina-Borja M, Chin RF, et al. A population-based study of newly diagnosed epilepsy in infants. Epilepsia
2013;54(3):437–45.
[2] Glass HC, Shellhaas RA, Wusthoﬀ CJ, Chang T, Abend NS, Chu CJ, et al.
Contemporary proﬁle of seizures in neonates: a prospective cohort study. J Pediatr
2016;174. 98-103 e1.
[3] Bartha AI, Shen J, Katz KH, Mischel RE, Yap KR, Ivacko JA, et al. Neonatal seizures:
multicenter variability in current treatment practices. Pediatr Neurol
2007;37(2):85–90.
[4] Wilmshurst JM, Gaillard WD, Vinayan KP, Tsuchida TN, Plouin P, et al. Summary of
recommendations for the management of infantile seizures: task force report for the
ILAE commission of pediatrics. Epilepsia 2015;56(8):1185–97.
[5] Caraballo R, Vaccarezza M, Cersosimo R, Rios V, Soraru A, Arroyo H, et al. Longterm follow-up of the ketogenic diet for refractory epilepsy: multicenter
Argentinean experience in 216 pediatric patients. Seizure 2011;20(8):640–5.
[6] Wibisono C, Rowe N, Beavis E, Kepreotes H, Mackie FE, Lawson JA, et al. Ten-year
single-center experience of the ketogenic diet: factors inﬂuencing eﬃcacy, tolerability, and compliance. J Pediatr 2015;166(4). 1030-6 e1.
[7] Kayyali HR, Gustafson M, Myers T, Thompson L, Williams M, Abdelmoity A.
Ketogenic diet eﬃcacy in the treatment of intractable epileptic spasms. Pediatr
Neurol 2014;50(3):224–7.
[8] Hong AM, Turner Z, Hamdy RF, Kossoﬀ EH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants.
Epilepsia 2010;51(8):1403–7.
[9] Arthur I, Eidelman M, Richard J, Schanler MD. Breastfeeding and the use of human
milk. Pediatrics 2012;129(3):15.
[10] Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy,
carbohydrate, ﬁber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet
Assoc 2002;102(11):1621–30.
[11] Cole NW, Pfeifer Heidi H, Thiele Elizabeth A. Initiating and maintaining the ketogenic diet in breastfed infants. ICAN Infant Child Adolesc Nutr 2010;2(3):4.
[12] Fenton C, Randall Rebecca, Groveman Sue A, Chee Claire M, Christina Bergqvist
AG. Use of expressed breast milk with the ketogenic diet. ICAN Infant Child Adolesc
Nutr 2015;7(6):5.

Conﬂict of interest disclosure
J.B. Le Pichon has no conﬂicts of interest to disclose.
43

